Physician profile
Henry K Siu
NPI 1871777607
$233,967.29
in general payments reported to CMS, 2019-2025
43 companies · $69K in 2025
The $69K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,999 · 2020: $2,028 · 2021: $54K · 2022: $44K · 2023: $13K · 2024: $50K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $95K · Food and Beverage: $20K · Consulting Fee: $15K · Travel and Lodging: $2,611 · Honoraria: $63.00 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $94,580.56 |
| Food and Beverage | $20,064.61 |
| Consulting Fee | $14,500.00 |
| Travel and Lodging | $2,610.65 |
| Honoraria | $63.00 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $97,988.45 | 2020-2025 | Nexletol, Nexlizet |
| Novo Nordisk INC | $82,746.78 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $19,988.49 | 2022-2025 | |
| Agepha Pharma Fz LLC | $5,367.79 | 2025 | Lodoco |
| Abbott Laboratories | $3,698.92 | 2019-2025 | Diamondback Coronary, Diamondback Peripheral, Optis |
| Medtronic, INC. | $2,976.34 | 2021-2025 | Closurerfs, Resolute Onyx, Symplicity G3 |
| Spectrawave, INC | $2,299.92 | 2024-2025 | Hypervue Imaging System, Starlight Imaging Catheter |
| Cardiovascular Systems INC. | $2,080.75 | 2019-2023 | Diamondback Peripheral |
| Novartis Pharmaceuticals Corporation | $1,601.75 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $1,509.53 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $1,375.63 | 2019-2025 | Watchman Flx, Watchman Access System |
| Philips North America LLC | $1,225.90 | 2019-2024 | (Bq9) Coronary Ivus |
| Astrazeneca Pharmaceuticals Lp | $1,143.32 | 2019-2025 | Farxiga, Wainua, Lokelma |
| E.R. Squibb & Sons, L.L.C. | $1,126.52 | 2019-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $976.24 | 2022-2025 | Verquvo, Capvaxive |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $948.27 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $945.26 | 2019-2025 | Jardiance |
| Ibsa Pharma INC. | $728.94 | 2022-2024 | Licart, Tirosint, Tirosint |
| Lilly USA, LLC | $718.57 | 2022-2025 | Mounjaro, Zepbound |
| Biotronik INC. | $622.65 | 2024-2025 | Biomonitor |
| Amgen INC. | $605.68 | 2022-2025 | Repatha, Repatha |
| Bard Peripheral Vascular, INC. | $444.66 | 2020-2025 | Rotarexs 6 F X 135 Cm, Venclose Maven Catheter |
| Abiomed | $295.44 | 2021-2025 | |
| Scpharmaceuticals INC. | $270.07 | 2025 | |
| Medtronic Vascular, INC. | $243.02 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $228.89 | 2021-2022 | |
| Amarin Pharma, INC. | $224.37 | 2019-2023 | |
| Bridgebio Pharma, INC. | $197.44 | 2025 | Attruby |
| Sanofi-Aventis U.S. LLC | $194.88 | 2021-2024 | |
| Glaxosmithkline, LLC. | $167.04 | 2023-2025 | Trelegy Ellipta |
| Saranas, INC. | $148.38 | 2021-2022 | |
| Heartflow, INC. | $144.94 | 2023 | Ffrct |
| Idorsia Pharmaceuticals US INC | $143.25 | 2025 | Tryvio |
| Phathom Pharmaceuticals, INC. | $125.42 | 2024 | Voquezna |
| Endologix LLC | $124.09 | 2025 | Torus Stent Graft System, Endocross Device |
| Becton, Dickinson and Company | $97.00 | 2025 | Introducer Needle |
| Lexicon Pharmaceuticals, INC. | $70.67 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.19 | 2019 | |
| Abbvie INC. | $35.26 | 2024-2025 | |
| Pfizer INC. | $29.42 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.76 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $14.40 | 2019 | |
| Gilead Sciences, INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Siu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.